Cargando…

Quantitative assessment of interstitial lung disease in Sjögren’s syndrome

BACKGROUND: Interstitial lung disease (ILD) is a frequent manifestation of Sjögren’s syndrome (SS), an autoimmune disease of salivary and lacrimal glands, and affects approximately 20% of patients. No clinical or serological features appear to be useful to predict its presence, severity or progressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guisado-Vasco, Pablo, Silva, Mario, Duarte-Millán, Miguel Angel, Sambataro, Gianluca, Bertolazzi, Chiara, Pavone, Mauro, Martín-Garrido, Isabel, Martín-Segarra, Oriol, Luque-Pinilla, José Manuel, Santilli, Daniele, Sambataro, Domenico, Torrisi, Sebastiano E., Vancheri, Ada, Gutiérrez, Marwin, Mejia, Mayra, Palmucci, Stefano, Mozzani, Flavio, Rojas-Serrano, Jorge, Vanchieri, Carlo, Sverzellati, Nicola, Ariani, Alarico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839858/
https://www.ncbi.nlm.nih.gov/pubmed/31703067
http://dx.doi.org/10.1371/journal.pone.0224772
_version_ 1783467501552664576
author Guisado-Vasco, Pablo
Silva, Mario
Duarte-Millán, Miguel Angel
Sambataro, Gianluca
Bertolazzi, Chiara
Pavone, Mauro
Martín-Garrido, Isabel
Martín-Segarra, Oriol
Luque-Pinilla, José Manuel
Santilli, Daniele
Sambataro, Domenico
Torrisi, Sebastiano E.
Vancheri, Ada
Gutiérrez, Marwin
Mejia, Mayra
Palmucci, Stefano
Mozzani, Flavio
Rojas-Serrano, Jorge
Vanchieri, Carlo
Sverzellati, Nicola
Ariani, Alarico
author_facet Guisado-Vasco, Pablo
Silva, Mario
Duarte-Millán, Miguel Angel
Sambataro, Gianluca
Bertolazzi, Chiara
Pavone, Mauro
Martín-Garrido, Isabel
Martín-Segarra, Oriol
Luque-Pinilla, José Manuel
Santilli, Daniele
Sambataro, Domenico
Torrisi, Sebastiano E.
Vancheri, Ada
Gutiérrez, Marwin
Mejia, Mayra
Palmucci, Stefano
Mozzani, Flavio
Rojas-Serrano, Jorge
Vanchieri, Carlo
Sverzellati, Nicola
Ariani, Alarico
author_sort Guisado-Vasco, Pablo
collection PubMed
description BACKGROUND: Interstitial lung disease (ILD) is a frequent manifestation of Sjögren’s syndrome (SS), an autoimmune disease of salivary and lacrimal glands, and affects approximately 20% of patients. No clinical or serological features appear to be useful to predict its presence, severity or progression, and chest high-resolution computed tomography (CT) remains the gold standard for diagnosis. Semiquantitative CT (SQCT) based on visual assessment (Goh and Taouli scoring) can estimate ILD extent, although it is burdened by relevant intra- and interobserver variability. Quantitative chest CT (QCT) is a promising alternative modality to assess ILD severity. AIM: To determine whether QCT assessment can identify extensive or limited lung disease in patients with SS and ILD. METHODS: This multi-center, cross-sectional and retrospective study enrolled patients with SS and a chest CT scan. SQCT assessment was carried out in a blinded and centralized manner to calculate both Goh and Taouli scores. An operator-independent analysis of all CT scans with the open-source software platform Horos was used to evaluate the QCT indices. Patients were classified according to the extent of ILD and differences in QCT index distribution were investigated with non-parametric tests. RESULTS: From a total of 102 consecutive patients with SS, the prevalence of ILD was 35.3% (36/102). There was a statistically significant difference in QCT index distribution between the SS with ILD and SS without ILD groups (p<0.001). Moreover, SS-ILD patients with ILD >20% (by Goh score) had a QCT index statistically different from those with limited ILD extent (p<0.001). Finally, QCT indices showed a moderate-to-good correlation with the Goh and Taouli scores (from 0.44 to 0.65; p<0.001). CONCLUSIONS: QCT indices can identify patients with SS and ILD and discriminate those with lesser or greater lung disease.
format Online
Article
Text
id pubmed-6839858
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-68398582019-11-15 Quantitative assessment of interstitial lung disease in Sjögren’s syndrome Guisado-Vasco, Pablo Silva, Mario Duarte-Millán, Miguel Angel Sambataro, Gianluca Bertolazzi, Chiara Pavone, Mauro Martín-Garrido, Isabel Martín-Segarra, Oriol Luque-Pinilla, José Manuel Santilli, Daniele Sambataro, Domenico Torrisi, Sebastiano E. Vancheri, Ada Gutiérrez, Marwin Mejia, Mayra Palmucci, Stefano Mozzani, Flavio Rojas-Serrano, Jorge Vanchieri, Carlo Sverzellati, Nicola Ariani, Alarico PLoS One Research Article BACKGROUND: Interstitial lung disease (ILD) is a frequent manifestation of Sjögren’s syndrome (SS), an autoimmune disease of salivary and lacrimal glands, and affects approximately 20% of patients. No clinical or serological features appear to be useful to predict its presence, severity or progression, and chest high-resolution computed tomography (CT) remains the gold standard for diagnosis. Semiquantitative CT (SQCT) based on visual assessment (Goh and Taouli scoring) can estimate ILD extent, although it is burdened by relevant intra- and interobserver variability. Quantitative chest CT (QCT) is a promising alternative modality to assess ILD severity. AIM: To determine whether QCT assessment can identify extensive or limited lung disease in patients with SS and ILD. METHODS: This multi-center, cross-sectional and retrospective study enrolled patients with SS and a chest CT scan. SQCT assessment was carried out in a blinded and centralized manner to calculate both Goh and Taouli scores. An operator-independent analysis of all CT scans with the open-source software platform Horos was used to evaluate the QCT indices. Patients were classified according to the extent of ILD and differences in QCT index distribution were investigated with non-parametric tests. RESULTS: From a total of 102 consecutive patients with SS, the prevalence of ILD was 35.3% (36/102). There was a statistically significant difference in QCT index distribution between the SS with ILD and SS without ILD groups (p<0.001). Moreover, SS-ILD patients with ILD >20% (by Goh score) had a QCT index statistically different from those with limited ILD extent (p<0.001). Finally, QCT indices showed a moderate-to-good correlation with the Goh and Taouli scores (from 0.44 to 0.65; p<0.001). CONCLUSIONS: QCT indices can identify patients with SS and ILD and discriminate those with lesser or greater lung disease. Public Library of Science 2019-11-08 /pmc/articles/PMC6839858/ /pubmed/31703067 http://dx.doi.org/10.1371/journal.pone.0224772 Text en © 2019 Guisado-Vasco et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Guisado-Vasco, Pablo
Silva, Mario
Duarte-Millán, Miguel Angel
Sambataro, Gianluca
Bertolazzi, Chiara
Pavone, Mauro
Martín-Garrido, Isabel
Martín-Segarra, Oriol
Luque-Pinilla, José Manuel
Santilli, Daniele
Sambataro, Domenico
Torrisi, Sebastiano E.
Vancheri, Ada
Gutiérrez, Marwin
Mejia, Mayra
Palmucci, Stefano
Mozzani, Flavio
Rojas-Serrano, Jorge
Vanchieri, Carlo
Sverzellati, Nicola
Ariani, Alarico
Quantitative assessment of interstitial lung disease in Sjögren’s syndrome
title Quantitative assessment of interstitial lung disease in Sjögren’s syndrome
title_full Quantitative assessment of interstitial lung disease in Sjögren’s syndrome
title_fullStr Quantitative assessment of interstitial lung disease in Sjögren’s syndrome
title_full_unstemmed Quantitative assessment of interstitial lung disease in Sjögren’s syndrome
title_short Quantitative assessment of interstitial lung disease in Sjögren’s syndrome
title_sort quantitative assessment of interstitial lung disease in sjögren’s syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839858/
https://www.ncbi.nlm.nih.gov/pubmed/31703067
http://dx.doi.org/10.1371/journal.pone.0224772
work_keys_str_mv AT guisadovascopablo quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT silvamario quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT duartemillanmiguelangel quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT sambatarogianluca quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT bertolazzichiara quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT pavonemauro quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT martingarridoisabel quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT martinsegarraoriol quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT luquepinillajosemanuel quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT santillidaniele quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT sambatarodomenico quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT torrisisebastianoe quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT vancheriada quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT gutierrezmarwin quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT mejiamayra quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT palmuccistefano quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT mozzaniflavio quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT rojasserranojorge quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT vanchiericarlo quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT sverzellatinicola quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome
AT arianialarico quantitativeassessmentofinterstitiallungdiseaseinsjogrenssyndrome